1. Investment Snapshot

2. Thesis

3. Valuation & Price Target

4. Business & Product Moat

5. People & Governance

6. Market & Macro

7. Financial Quality

8. Risk Register

9. Prediction Market

10. 𝕏 Posts

Discussion

Neumora Therapeutics, Inc. (NMRA) IPO | IPOSignal

Sections

1. Investment Snapshot

2. Capital Structure

3. Valuation

Discussion

Inline comments

Investment Snapshot

Capital Structure

Valuation

Discussion

Neumora Therapeutics, Inc.

Analyst research, target price, syndicate analytics, and valuation sections are included with an active subscription. View plans

Investment Snapshot

S-1/A All Filings

Symbol

NMRA

Event Date

2023-09-15

Sector

Health Care

Subsector

Biotechnology

Offer Range

—

Shares Offered

14.71M

Shares Outstanding Pre-IPO

32.82M

Total Shares Post-IPO

151.95M

Market Cap

—

Target Price

$00.00

Implied Upside vs Midpoint

$00.00

Description

—

Capital Structure

Post-IPO economic shares by class.

Class	Shares	% Economic
Common Stock (listed) 1 vote per share	151.95M	100.0%
Total economic shares	151.95M	100%

Not counted toward economic shares

Convertible Preferred Stock

Pre-conversion — already in the listed class

104.42M

Valuation

████████████████████